Low-dose intra-arterial urokinase and aggressive mechanical clot disruption for acute ischemic stroke after failure of intravenous thrombolysis

American Journal of Neuroradiology

Volumn 31, Issue 1, 2010, Pages 161-164

  Yoon, Woon ^a   Park, M S ^a   Cho, K H ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; UROKINASE;

ACUTE ISCHEMIC STROKE; ADULT; AGED; AGGRESSIVE MECHANICAL CLOT DISRUPTION; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; RECANALIZATION; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TREATMENT FAILURE; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 75749105896     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1746     Document Type: Article

References (21)

1. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86
2. von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992;23:646-52
3. Lee KY, Han SW, Kim SH, et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007;38:192-93
4. The IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004;35:904-12
5. The IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007;38:2127-35
6. Lee KY, Kim DI, Kim SH, et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470-75
7. Kim DJ, Kim DI, Kim SH, et al. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005;47:616-21
8. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80-84
9. Vora NA, Gupta R, Thomas AJ, et al. Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. AJNR Am J Neuroradiol 2007;28:1391-94
10. Brekenfeld C, Remonda L, Nedeltchev K, et al. Symptomatic intracranial hemorrhage after intra-arterial thrombolysis in acute ischemic stroke: assessment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry 2007;78:280-85
11. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007;38:431-40
12. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319-29
13. Sorimachi T, Fujii Y, Tsuchiya N, et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004;25:1391-402
14. Noser EA, Shaltoni HM, Hall CE, et al. Aggressive mechanical clot disruption. A safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292-96
15. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-87
16. Yoon W, Seo JJ, Cho KH, et al. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005;237:620-26
17. Labiche LA, Al-Senani F, Wojner AW, et al. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003;34:695-98
18. Alexandrov AV, Burgin WS, Demchuk AM, et al. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-902
19. Mandava P, Kent TA. Intra-arterial therapies for acute ischemic stroke. Neurology 2007;68:2132-39
20. Nakano S, Iseda T, Yoneyama T, et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion. An alternative option to intra-arterial thrombolysis. Stroke 2002;33:2872-76
21. Ikushima I, Ohta H, Hirai T, et al. Balloon catheter disruption of middle cerebral artery thrombus in conjunction with thrombolysis for the treatment of acute middle cerebral artery embolism. AJNR Am J Neuroradiol 2007;28:513-17